A 28-year-old man from Chennai presents with fever, severe headache, myalgia, and rash for 5 days. He reports that the fever is continuous (not periodic). On examination, he has a petechial rash on the trunk and limbs, hepatomegaly, and a positive tourniquet test. Platelet count is 85,000/μL (down from 150,000/μL 2 days ago). Dengue NS1 antigen is positive. What is the most appropriate management according to NVBDCP guidelines for dengue hemorrhagic fever (DHF)?

Explanation

## Diagnosis: Dengue Hemorrhagic Fever (DHF) **Key Point:** This patient meets criteria for DHF: 1. Fever (5 days, continuous pattern typical of dengue) 2. Hemorrhagic manifestations: petechial rash, positive tourniquet test, thrombocytopenia (85,000/μL with declining trend) 3. Plasma leakage: hepatomegaly (organ involvement) 4. Positive NS1 antigen (confirms dengue in acute phase) ## NVBDCP Classification and Severity | Grade | Criteria | Management | |-------|----------|------------| | **Dengue Fever (DF)** | Fever + 2 of: headache, myalgia, rash, hemorrhagic manifestations; no plasma leakage | Outpatient ORS, paracetamol, follow-up | | **DHF Grade I** | Fever + hemorrhagic manifestations (petechiae, positive tourniquet) + no plasma leakage signs | Admit, IV fluids if unable to maintain oral intake | | **DHF Grade II** | DHF Grade I + spontaneous bleeding (GI, gum, vaginal) | Admit, IV crystalloids, monitor hematocrit | | **DHF Grade III** | DHF Grade II + signs of plasma leakage (ascites, pleural effusion, hypotension) | Admit ICU, aggressive IV fluids, monitor CVP | | **DHF Grade IV** | Shock (systolic BP <90 mmHg, weak pulse, cold extremities) | ICU, vasopressors, blood products | This patient is **Grade I–II DHF** (hemorrhagic manifestations, thrombocytopenia with declining trend, hepatomegaly). ## Management Algorithm ```mermaid flowchart TD A[Dengue with hemorrhagic signs]:::outcome --> B{Plasma leakage signs?}:::decision B -->|No| C[DHF Grade I-II]:::outcome B -->|Yes| D[DHF Grade III-IV]:::outcome C --> E[Admit, IV crystalloids]:::action D --> F[ICU admission, aggressive fluids]:::action E --> G[Monitor vitals, urine output, hematocrit]:::action F --> G G --> H{Platelet count?}:::decision H -->|<20,000 or <50,000 + bleeding| I[Transfuse platelets]:::action H -->|>50,000 no bleeding| J[Avoid transfusion, continue fluids]:::action I --> K[Reassess daily]:::action J --> K ``` ## Fluid Management (NVBDCP Guidelines) **High-Yield:** The cornerstone of DHF management is **judicious IV fluid therapy**: 1. **Crystalloid choice**: Normal saline (0.9%) or Ringer's lactate 2. **Goal**: Maintain hematocrit at 20% (normal ~40%; rising hematocrit indicates hemoconcentration from plasma leakage) 3. **Monitoring**: Urine output (target ≥0.5 mL/kg/hr), vital signs, hematocrit every 6–12 hours 4. **Avoid**: Hypotonic fluids (risk of hyponatremia), NSAIDs (increase bleeding risk), aspirin 5. **Colloids**: Reserved for refractory shock unresponsive to crystalloids ## Platelet Transfusion Thresholds **Clinical Pearl:** Platelet transfusion is indicated ONLY if: - Count <20,000/μL (spontaneous bleeding risk), OR - Count <50,000/μL with active bleeding or planned invasive procedure This patient's count (85,000/μL) does NOT yet warrant transfusion; monitor for further decline. ## Contraindications and Pitfalls **Warning:** Do NOT: - Use NSAIDs (aspirin, ibuprofen) — increase bleeding risk - Administer antibiotics (dengue is viral; no bacterial superinfection) - Give corticosteroids (no evidence of benefit; increase secondary infection risk) - Discharge early (critical phase is days 3–7; plasma leakage peaks around day 5) - Transfuse unnecessarily (increases volume overload and pulmonary edema risk) ## Why Not the Other Options? **Mnemonic:** **AVOID** in dengue: - **A**ntibiotics (doxycycline, ceftriaxone) — dengue is viral - **V**olumetric overload (FFP, IVIG) — worsens plasma leakage - **O**utpatient discharge (DHF requires admission) - **I**mmunoglobulin (IVIG) — no evidence; wastes resources - **D**eferral of fluids (IV crystalloids are life-saving)